← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 11, 20268-KCompany UpdateJun 5, 20268-KResults of OperationsMay 5, 20268-KReg FD Disclosure · Company UpdateApr 17, 20268-KCompany UpdateApr 9, 20268-KReg FD Disclosure · Company UpdateMar 23, 20268-KResults of OperationsMar 12, 20268-KMaterial Agreement · Reg FD DisclosureFeb 18, 20268-KCompany UpdateFeb 12, 20268-KCompany UpdateJan 12, 20268-KReg FD Disclosure · Company UpdateDec 29, 20258-KCompany UpdateDec 15, 20258-KResults of OperationsNov 12, 20258-KCompany UpdateOct 29, 20258-KCompany UpdateOct 24, 20258-KCompany UpdateOct 20, 20258-KMaterial Agreement · Equity IssuanceOct 17, 20258-KReg FD Disclosure · Company UpdateOct 14, 20258-KCompany UpdateOct 8, 20258-KReg FD Disclosure · Company UpdateOct 6, 20258-KExit / Disposal CostsOct 2, 20258-KExecutive Change · Shareholder VoteSep 4, 20258-KResults of OperationsAug 11, 20258-KCompany UpdateJun 25, 20258-KCompany UpdateJun 20, 20258-KReg FD Disclosure · Company UpdateJun 2, 20258-KResults of OperationsMay 14, 20258-KMaterial Agreement · Company UpdateMay 8, 20258-KReg FD Disclosure · Company UpdateMay 7, 20258-KReg FD Disclosure · Company UpdateMar 31, 20258-KResults of OperationsMar 6, 20258-KReg FD Disclosure · Company UpdateDec 5, 20248-KResults of OperationsNov 12, 20248-KExecutive Change · Bylaw AmendmentNov 1, 20248-KReg FD Disclosure · Company UpdateOct 16, 20248-KReg FD Disclosure · Company UpdateOct 3, 20248-KMaterial Agreement · Company UpdateSep 30, 20248-KReg FD Disclosure · Company UpdateSep 23, 20248-KNew Debt / Obligation · Reg FD DisclosureSep 16, 20248-KCompany UpdateSep 9, 20248-KSecurity-Holder Rights · Bylaw AmendmentAug 26, 20248-KSecurity-Holder Rights · Bylaw AmendmentAug 16, 20248-KResults of OperationsAug 13, 20248-KReg FD Disclosure · Company UpdateJul 31, 20248-KReg FD Disclosure · Company UpdateMay 23, 20248-KCompany UpdateMay 16, 20248-KResults of OperationsMay 7, 20248-KMaterial AgreementMay 2, 20248-KReg FD Disclosure · Company UpdateApr 23, 20248-KReg FD Disclosure · Company UpdateApr 22, 20248-KReg FD DisclosureApr 16, 20248-KResults of OperationsMar 25, 20248-KReg FD Disclosure · Company UpdateFeb 7, 20248-KReg FD DisclosureJan 8, 20248-KResults of OperationsNov 13, 20238-KReg FD Disclosure · Company UpdateOct 23, 20238-KReg FD Disclosure · Company UpdateOct 17, 20238-KShareholder VoteOct 3, 20238-KBylaw AmendmentAug 11, 20238-KResults of OperationsAug 8, 20238-KReg FD Disclosure · Company UpdateAug 2, 20238-KReg FD Disclosure · Company UpdateJun 27, 20238-KResults of OperationsMay 11, 20238-KResults of OperationsMar 30, 20238-KRestatement · Company UpdateMar 10, 20238-KReg FD Disclosure · Company UpdateFeb 16, 20238-KReg FD Disclosure · Company UpdateJan 17, 20238-KReg FD Disclosure · Company UpdateJan 9, 20238-KMaterial AgreementDec 23, 20228-KExecutive ChangeDec 20, 20228-KResults of OperationsNov 10, 20228-KBylaw Amendment · Reg FD DisclosureOct 12, 20228-KExecutive Change · Shareholder VoteOct 3, 20228-KReg FD Disclosure · Company UpdateSep 30, 20228-KReg FD Disclosure · Company UpdateSep 27, 20228-KCompany UpdateSep 12, 20228-KReg FD Disclosure · Company UpdateSep 6, 20228-KResults of OperationsAug 11, 20228-KSecurity-Holder RightsAug 3, 20228-KMaterial Agreement · Equity IssuanceJul 29, 2022
Similar companies
Comparable business profile · signals at a glance